Methyl-Cantharidimide (MCA) Has Anticancer Efficacy in ABCB1- and ABCG2-Overexpressing and Cisplatin Resistant Cancer Cells

In this study, we investigated the efficacy of methyl-cantharidimide (MCA), a cantharidin (CTD) analog, as an anticancer drug, in cancer cells overexpressing either ABCB1 or ABCG2 transporters and in cisplatin-resistant cancer cells. The results indicated that: (i) MCA was efficacious in the ABCB1-o...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yi-Dong, Mao, Yong, Dong, Xing-Duo, Lei, Zi-Ning, Yang, Yuqi, Lin, Lizhu, Ashby, Charles R., Yang, Dong-Hua, Fan, Ying-Fang, Chen, Zhe-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333678/
https://www.ncbi.nlm.nih.gov/pubmed/32676451
http://dx.doi.org/10.3389/fonc.2020.00932

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333678/
https://www.ncbi.nlm.nih.gov/pubmed/32676451
http://dx.doi.org/10.3389/fonc.2020.00932

Ejemplares similares